Psycho-Oncological Intervention Through Counseling in Patients With Differentiated Thyroid Cancer in Treatment With Radioiodine (COUNTHY, NCT05054634): A Non-randomized Controlled Study.

cancer oncology psycho-oncology psychotherapy quality of life radioisotope therapy thyroid cancer

Journal

Frontiers in psychology
ISSN: 1664-1078
Titre abrégé: Front Psychol
Pays: Switzerland
ID NLM: 101550902

Informations de publication

Date de publication:
2022
Historique:
received: 30 08 2021
accepted: 17 01 2022
entrez: 14 3 2022
pubmed: 15 3 2022
medline: 15 3 2022
Statut: epublish

Résumé

Diagnosis and treatment of differentiated thyroid carcinomas (DTC) cause anxiety and depression. Additionally, these patients suffer hormonal alterations that are associated with psychological symptoms (e.g., changes in mood, emotional instability, and memory loss). This study aims to evaluate the effectiveness of a psycho-oncological intervention based on counseling to reduce anxiety and depression related to the treatment in patients with DTC. A non-randomized controlled study, with two groups [experimental group (EG), The difference of the posttreatment-baseline variation showed a statistically significant reduction in anxiety and depression in the EG in relation to the CG ( This study demonstrates significant benefits of psycho-oncological intervention based on counseling in anxiety, depression, QoL, and wellbeing of the patient with differentiated thyroid carcinomas.

Sections du résumé

Background UNASSIGNED
Diagnosis and treatment of differentiated thyroid carcinomas (DTC) cause anxiety and depression. Additionally, these patients suffer hormonal alterations that are associated with psychological symptoms (e.g., changes in mood, emotional instability, and memory loss). This study aims to evaluate the effectiveness of a psycho-oncological intervention based on counseling to reduce anxiety and depression related to the treatment in patients with DTC.
Methods UNASSIGNED
A non-randomized controlled study, with two groups [experimental group (EG),
Results UNASSIGNED
The difference of the posttreatment-baseline variation showed a statistically significant reduction in anxiety and depression in the EG in relation to the CG (
Conclusion UNASSIGNED
This study demonstrates significant benefits of psycho-oncological intervention based on counseling in anxiety, depression, QoL, and wellbeing of the patient with differentiated thyroid carcinomas.

Identifiants

pubmed: 35282223
doi: 10.3389/fpsyg.2022.767093
pmc: PMC8914112
doi:

Types de publication

Journal Article

Langues

eng

Pagination

767093

Informations de copyright

Copyright © 2022 Javaloyes, Crespo, Redal, Brugarolas, Botella, Escudero-Ortiz and Sureda.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Eur Thyroid J. 2013 Jun;2(2):93-101
pubmed: 24783046
Psychooncology. 1998 May-Jun;7(3):218-28
pubmed: 9638783
Eur J Endocrinol. 2005 Dec;153(6):755-63
pubmed: 16322380
Palliat Support Care. 2007 Jun;5(2):107-14
pubmed: 17578061
Arch Gen Psychiatry. 1995 Feb;52(2):100-13
pubmed: 7848046
Thyroid. 2006 Feb;16(2):109-42
pubmed: 16420177
Oncologist. 2013;18(3):336-44
pubmed: 23429740
Psychooncology. 2009 Aug;18(8):795-810
pubmed: 19090556
Qual Life Res. 2011 Nov;20(9):1411-7
pubmed: 21424541
J Psychosom Res. 1997 Jan;42(1):17-41
pubmed: 9055211
Endocr Relat Cancer. 2003 Dec;10(4):601-10
pubmed: 14713270
Cochrane Database Syst Rev. 2012 Nov 14;11:CD007064
pubmed: 23152241
Klin Onkol. 2016 Winter;29(6):439-444
pubmed: 27951721
Pain. 2014 Apr;155(4):746-754
pubmed: 24434732
Psychooncology. 2009 Jun;18(6):647-56
pubmed: 19039808
Thyroid. 2016 Nov;26(11):1605-1613
pubmed: 27605136
J Laryngol Otol. 2004 Jul;118(7):537-42
pubmed: 15318961
J Clin Endocrinol Metab. 2006 Sep;91(9):3389-93
pubmed: 16804044
Psychiatry. 2009 Spring;72(1):50-69
pubmed: 19366294
Cancer. 2003 Aug 15;98(4):854-64
pubmed: 12910531
Neuropsychiatr Dis Treat. 2016 May 02;12:1055-60
pubmed: 27194911
Psychooncology. 2007 Mar;16(3):171-80
pubmed: 16858670
Int J Endocrinol. 2016;2016:4309087
pubmed: 27069476
Thyroid. 2015 Dec;25(12):1313-21
pubmed: 26431811
Eur J Nucl Med Mol Imaging. 2008 Oct;35(10):1941-59
pubmed: 18670773
Acta Psychiatr Scand. 1983 Jun;67(6):361-70
pubmed: 6880820
Clin Oncol. 1983 Dec;9(4):319-24
pubmed: 6362943
Gac Sanit. 2005 Mar-Apr;19(2):135-50
pubmed: 15860162
Thyroid. 2009 Nov;19(11):1167-214
pubmed: 19860577
Otolaryngol Head Neck Surg. 2015 Apr;152(4):644-9
pubmed: 25573679
Int J Behav Med. 2012 Dec;19(4):535-42
pubmed: 21931958
J Clin Endocrinol Metab. 2013 Jul;98(7):2701-8
pubmed: 23678034
Psychooncology. 2014 Aug;23(8):928-35
pubmed: 24535848
Psychooncology. 2003 Sep;12(6):532-46
pubmed: 12923794
Qual Life Res. 2006 May;15(4):695-703
pubmed: 16688502
Oral Oncol. 2015 Jun;51(6):S1-5
pubmed: 25920747
Psychooncology. 2012 Oct;21(10):1136-9
pubmed: 21726017

Auteurs

Nuria Javaloyes (N)

Plataforma de Oncología, Hospital Quirónsalud Torrevieja, Torrevieja, Spain.

Aurora Crespo (A)

Servicio de Medicina Nuclear, Hospital Universitari Sant Joan, Alicante, Spain.

M Carmen Redal (MC)

Servicio de Medicina Nuclear, Hospital Clínico Universitario de Valencia, Valencia, Spain.

Antonio Brugarolas (A)

Plataforma de Oncología, Hospital Quirónsalud Torrevieja, Torrevieja, Spain.

Lara Botella (L)

Plataforma de Oncología, Hospital Quirónsalud Torrevieja, Torrevieja, Spain.

Vanesa Escudero-Ortiz (V)

Facultad de Ciencias de la Salud, Grupo de Investigación en Farmacia y Nutrición Clínica, Universidad CEU Cardenal, Elche, Spain.

Manuel Sureda (M)

Plataforma de Oncología, Hospital Quirónsalud Torrevieja, Torrevieja, Spain.

Classifications MeSH